Description
What are Sildigra 225 Mg Tablets?
Sildigra 225 Mg Tablets are an oral erectile dysfunction (ED) medication manufactured by RSM Multilink LLP, a pharmaceutical company based in India. Each tablet contains 225 mg of Sildenafil Citrate as the active ingredient. Sildenafil Citrate is a selective phosphodiesterase type 5 (PDE5) inhibitor that promotes penile erection by increasing blood flow to the erectile tissue during sexual stimulation.
Sildigra 225 is used by men who require a higher-strength sildenafil formulation and are under close medical supervision. Each pack contains 100 tablets, making it suitable for ongoing treatment under the direction of a qualified healthcare provider.
Composition and Product Details
| Brand Name | Sildigra 225 |
|---|---|
| Generic Name | Sildenafil Citrate |
| Strength | 225 mg per tablet |
| Dosage Form | Oral tablet |
| Pack Size | 100 tablets |
| Manufacturer | RSM Multilink LLP, India |
| Therapeutic Class | PDE5 Inhibitor / Erectile Dysfunction Agent |
| Prescription Required | Yes |
⚠ Important Medical Notice — Supra-Maximal Dose
Sildigra 225 Mg contains 225 mg of sildenafil, which is 2.25 times the maximum approved dose of 100 mg established by regulatory authorities including the U.S. FDA and the European Medicines Agency (EMA). This product should only be used under direct supervision of a licensed physician. Self-medication at this dose carries a substantially increased risk of serious adverse effects including severe hypotension, priapism, vision changes, and cardiovascular events. If you are looking for a standard-strength sildenafil option, please consult your doctor regarding 50 mg or 100 mg formulations.
About Sildenafil Citrate
Sildenafil Citrate is one of the most extensively studied oral medications for erectile dysfunction. It was first approved by the U.S. Food and Drug Administration (FDA) in March 1998 under the brand name Viagra and has since been prescribed to hundreds of millions of men worldwide.
Sildenafil belongs to the pharmacological class of PDE5 inhibitors. It works specifically within the smooth muscle tissue of the penis, enabling an erection when combined with sexual arousal. Sildenafil does not cause an erection on its own; sexual stimulation is required to initiate the natural arousal response. The standard approved dosing range in adults is 25 mg to 100 mg, taken approximately 30 to 60 minutes before anticipated sexual activity.
How Sildigra 225 Mg Tablets Work
During sexual stimulation, nitric oxide (NO) is released from nerve endings and endothelial cells within the corpus cavernosum of the penis. Nitric oxide activates the enzyme guanylate cyclase, which increases levels of cyclic guanosine monophosphate (cGMP). Elevated cGMP causes smooth muscle relaxation in the penile arteries and sinusoidal spaces, allowing increased blood inflow and resulting in an erection.
Sildenafil inhibits the enzyme phosphodiesterase type 5 (PDE5), which normally breaks down cGMP. By blocking PDE5, sildenafil maintains elevated cGMP levels, thereby prolonging and enhancing the smooth muscle relaxation and blood engorgement needed for a satisfactory erection. The effect typically begins within 30 to 60 minutes of oral ingestion and may last for 4 to 6 hours.
At the 225 mg dose, these effects are markedly amplified compared to the approved 100 mg maximum, which is why medical supervision is essential at this strength.
Indications and Uses
Sildigra 225 Mg Tablets are indicated for the management of erectile dysfunction (ED) in adult men. Erectile dysfunction is defined as the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. ED can result from:
- Vascular conditions (atherosclerosis, hypertension, diabetes mellitus)
- Neurological disorders (spinal cord injury, multiple sclerosis, Parkinson’s disease)
- Hormonal imbalances (hypogonadism, hyperprolactinaemia)
- Psychological factors (anxiety, depression, relationship issues)
- Medication side effects (antidepressants, antihypertensives)
This product is indicated only where standard doses have proven inadequate and a physician has specifically recommended a higher-strength formulation.
Dosage and Administration
Dosage must be determined exclusively by the prescribing physician based on individual clinical assessment. General guidelines for sildenafil at approved doses are as follows; the physician may adjust these for higher-strength formulations:
- Recommended administration: Taken orally with water, approximately 30–60 minutes before sexual activity
- Frequency: Once daily only; do not exceed one dose in a 24-hour period
- Food interaction: May be taken with or without food; high-fat meals can delay onset of action by approximately 60 minutes
- Alcohol: Avoid excessive alcohol consumption as it may reduce efficacy and increase risk of side effects including hypotension
Never alter your prescribed dose without medical advice.
Special Populations
Elderly (≥65 years)
Older men typically have higher plasma sildenafil concentrations due to reduced hepatic and renal clearance. A starting dose of 25 mg is recommended for the general elderly population; high-strength formulations like Sildigra 225 require close physician oversight in this group.
Renal Impairment
Mild to moderate renal impairment (creatinine clearance 30–80 mL/min) does not significantly affect sildenafil pharmacokinetics. Severe renal impairment (CrCl <30 mL/min) increases exposure; dose adjustment is required.
Hepatic Impairment
Hepatic impairment reduces sildenafil clearance. This product is contraindicated in severe hepatic impairment (Child-Pugh Class C).
Paediatric Use
Sildigra 225 Mg is not intended for use in individuals under 18 years of age.
Precautions and Warnings
- Cardiovascular risk: Sexual activity carries an inherent cardiovascular risk. Assess cardiac status before prescribing. Sildenafil is not recommended in men for whom sexual activity is inadvisable due to underlying cardiovascular conditions.
- Hypotension: Sildenafil lowers blood pressure. Concurrent use with other antihypertensives or substances that lower blood pressure requires medical supervision.
- Priapism: Prolonged, painful erections unrelated to sexual stimulation (priapism) have been reported. Seek immediate medical attention if an erection lasts more than 4 hours.
- Vision changes: Rare cases of non-arteritic anterior ischaemic optic neuropathy (NAION) have been reported. Discontinue use immediately if sudden vision loss occurs.
- Hearing loss: Sudden hearing loss or tinnitus has been reported in association with PDE5 inhibitors. Discontinue and seek medical advice promptly.
- Sickle cell anaemia / retinitis pigmentosa: Use with caution in patients with these conditions.
Contraindications
- Nitrates (absolute contraindication): Concurrent use with any form of nitrate medication (e.g., glyceryl trinitrate, isosorbide mononitrate/dinitrate, amyl nitrite “poppers”) is absolutely contraindicated. The combination may cause a life-threatening drop in blood pressure.
- Riociguat: Concomitant use with this soluble guanylate cyclase stimulator is contraindicated.
- Severe hepatic impairment
- Recent stroke or myocardial infarction (within the last 6 months)
- Severe hypotension (resting blood pressure below 90/50 mmHg)
- Hypersensitivity to sildenafil or any excipients in the formulation
Side Effects
All sildenafil products may cause side effects; these are more likely and more pronounced at higher doses such as 225 mg. Side effects include:
Common (may affect up to 1 in 10 users)
- Headache
- Facial flushing and warmth
- Nasal congestion or runny nose
- Indigestion / dyspepsia
- Visual disturbances (altered colour perception, blurred vision)
Uncommon
- Dizziness or lightheadedness
- Palpitations
- Back pain, muscle pain
- Skin rash
- Nausea
Rare but Serious
- Priapism (prolonged painful erection — seek emergency care)
- Severe hypotension
- NAION (sudden vision loss)
- Sudden hearing loss
- Severe allergic reaction (anaphylaxis)
Report any unexpected or severe side effects to your doctor or pharmacist immediately.
Drug Interactions
- Nitrates: Absolutely contraindicated — risk of severe hypotension and death.
- Riociguat: Contraindicated — excessive blood pressure lowering.
- Alpha-blockers (e.g., tamsulosin, doxazosin): Increased risk of symptomatic hypotension. Use lowest doses and with caution.
- HIV protease inhibitors (e.g., ritonavir, saquinavir): Strong CYP3A4 inhibitors that markedly increase sildenafil plasma levels. Maximum sildenafil 25 mg per 48 hours recommended.
- Ketoconazole / itraconazole: CYP3A4 inhibitors — may increase sildenafil levels.
- Rifampicin, carbamazepine, phenytoin: CYP3A4 inducers — may reduce sildenafil efficacy.
- Antihypertensive medications: Additive blood pressure-lowering effect; monitor closely.
- Alcohol: May enhance hypotensive effects; limit or avoid.
Related Sildenafil Products on IndoGenMed
If you are looking for standard-approved sildenafil dosages or alternatives, IndoGenMed carries a range of sildenafil products from trusted manufacturers:
- Sildigra 250 Mg Tablets — The 250 mg strength of Sildigra by RSM Multilink LLP, for patients requiring even higher-strength sildenafil under physician supervision.
- Cenforce 100 Mg Tablets — One of the most popular FDA-equivalent-dose sildenafil brands from Centurion Laboratories.
- Fildena 100 Mg Tablets — Sildenafil 100 mg from Fortune Healthcare, a trusted Indian generics manufacturer.
- Suhagra 100 Mg Tablets — Cipla’s branded sildenafil offering for erectile dysfunction at the standard 100 mg dose.
- Vigora 100 Mg Tablets — Sildenafil 100 mg manufactured by German Remedies, a Viatris/Upjohn subsidiary.
- Vidalista 20 Mg Tadalafil Tablets — For patients who prefer a longer-acting PDE5 inhibitor; tadalafil offers up to 36 hours of activity.
Storage Instructions
- Store below 25°C (77°F) in a cool, dry place away from direct sunlight and moisture
- Keep the tablets in their original blister packaging until use
- Store out of reach of children and pets
- Do not use tablets past the printed expiry date
- Do not store in a bathroom or near a sink where humidity is high
Frequently Asked Questions
Q: Is 225 mg of sildenafil safe?
A: The maximum dose of sildenafil approved by the FDA and EMA is 100 mg. Doses above this level, including 225 mg, carry an increased risk of serious adverse effects including severe blood pressure drops, priapism, vision disturbances, and cardiovascular events. Use of Sildigra 225 should only occur under close physician supervision.
Q: How long does Sildigra 225 take to work?
A: As with all sildenafil formulations, Sildigra 225 typically begins to take effect within 30 to 60 minutes of ingestion. Sexual stimulation is required for the medication to produce an erection. A heavy meal, particularly one high in fat, may delay the onset by up to 60 minutes.
Q: Can I take Sildigra 225 with alcohol?
A: Alcohol should be avoided or strictly limited when taking any sildenafil product. Both alcohol and sildenafil lower blood pressure, and combining them increases the risk of hypotension, dizziness, and impaired sexual performance. The NHS advises avoiding excessive alcohol intake when using PDE5 inhibitors.
Q: What is the difference between Sildigra 225 and Sildigra 250?
A: Sildigra 250 Mg Tablets contain 25 mg more sildenafil per tablet than Sildigra 225, both exceed the FDA-approved 100 mg maximum dose. Both products are manufactured by RSM Multilink LLP and are only appropriate under physician supervision for patients who have not achieved adequate response at lower doses.
Q: Are Sildigra 225 tablets available without a prescription?
A: No. All sildenafil-containing products, including Sildigra 225, require a valid prescription from a licensed physician. This is a prescription-only medicine, and its use without medical supervision is not recommended and may be harmful.
References
- U.S. Food and Drug Administration (FDA). Viagra (sildenafil citrate) Prescribing Information. Pfizer Inc. Available at: FDA.gov
- European Medicines Agency (EMA). Sildenafil — Summary of Product Characteristics. Available at: EMA.europa.eu
- NHS. Sildenafil (Viagra): uses, dosage, side effects and warnings. NHS.uk. Available at: NHS.uk
- MedlinePlus. Sildenafil. U.S. National Library of Medicine. Available at: MedlinePlus.gov
- Goldstein I, et al. “Oral sildenafil in the treatment of erectile dysfunction.” New England Journal of Medicine. 1998;338(20):1397–1404.

Reviews
There are no reviews yet.